LOS GATOS, Calif., February 14, 2024 – Orlucent was featured twice in Clinical Lab Products, a magazine for the clinical laboratory industry that features product and technology news. The articles describe Orlucent’s breakthrough molecular imaging technology that detects a biomarker associated with early invasive melanoma development and allows physicians to determine which moles require further evaluation through pathology from those of less concern that can be monitored. “Advancements in both molecular imaging and pathology form the basis for the Orlucent technology,” said Catherine Shachaf PhD, President and Chief Scientific Officer.